Saturday, October 3, 2026

Back to today

From X

Nike, Part Two: The Deep Dive

Nike’s second Latticework program examines the company and the global athletic footwear and apparel industry for professional investors.

Nike, Part One: The Story

Nike grew from a $1,000 shoe-distribution venture in 1964 into the largest sports brand, using athlete endorsements, product innovation and…

KRYS · short

Krystal Biotech INC

Krystal Biotech is a profitable commercial-stage biotech with an $8.7 billion enterprise value and one FDA-approved topical gene therapy,…

New Buy : Zoetis 🐕

Zoetis trades near 10x EV/EBIT after its selloff, with animal-health leadership, a $9.5 billion revenue base and companion-animal demand…

Publications we follow

Every publication on this site, hand-picked.

128 publications

Newsletters 106

X accounts we follow

Every account on this site, hand-picked.

84 accounts

Investor letters we follow

189 firms

Sectors

Ordered by how often our editor reaches for them.